A Preclinical Evaluation of Antimycin A as a Potential Antilung Cancer Stem Cell Agent

Drug resistance and tumor recurrence are major obstacles in treating lung cancer patients. Accumulating evidence considers lung cancer stem cells (CSCs) as the major contributor to these clinical challenges. Agents that can target lung CSCs could potentially provide a more effective treatment than t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Chi-Tai, Su, Chun-Li, Huang, Chi-Ying F., Lin, Justin Kung-Yi, Lee, Wei-Hwa, Chang, Peter M.-H., Kuo, Yu-Lun, Liu, Yu-Wen, Wang, Liang-Shun, Wu, Chih-Hsiung, Shieh, Yi-Shing, Jan, Yi-Hua, Chuang, Yung-Jen, Hsiao, Michael, Wu, Alexander T. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693105/
https://www.ncbi.nlm.nih.gov/pubmed/23840269
http://dx.doi.org/10.1155/2013/910451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693105/
https://www.ncbi.nlm.nih.gov/pubmed/23840269
http://dx.doi.org/10.1155/2013/910451

Ejemplares similares